Correction: Systemically administered peptain-1 inhibits retinal ganglion cell death in animal models: implications for neuroprotection in glaucoma
Cell Death Discov
.
2019 Jul 31:5:122.
doi: 10.1038/s41420-019-0201-7.
eCollection 2019.
Authors
Dorota L Stankowska
#
1
,
Mi-Hyun Nam
#
2
,
Rooban B Nahomi
2
,
Renuka M Chaphalkar
1
,
Sandip K Nandi
2
,
Rafal Fudala
3
,
Raghu R Krishnamoorthy
1
,
Ram H Nagaraj
2
4
Affiliations
1
1Department of Pharmacology and Neuroscience, North Texas Eye Research Institute, UNT Health Science Center, Fort Worth, TX 76107 USA.
2
2Sue Anschutz-Rodgers Eye Center and Department of Ophthalmology, University of Colorado School of Medicine, Aurora, CO 80045 USA.
3
3Department of Microbiology, Immunology and Genetics, UNT Health Science Center, Fort Worth, TX 76107 USA.
4
4Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado, Aurora, CO 80045 USA.
#
Contributed equally.
PMID:
31372242
PMCID:
PMC6668458
DOI:
10.1038/s41420-019-0201-7
Abstract
[This corrects the article DOI: 10.1038/s41420-019-0194-2.].
Publication types
Published Erratum
Grants and funding
R01 EY028179/EY/NEI NIH HHS/United States